Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNO as Adjunct to Neonatal Resuscitation
NCT01220687Phase 2Completed
- Sponsor
- University of Oklahoma
- Start
- Apr 2011
- Primary completion
- Jan 2017
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory distress syndrome (RDS) comparing iNO Group with Placebo Group (2 arms). Primary endpoints: Maximum Fractional Inspired Oxygen Percent at 20 minutes, Rate of Hyperoxia at 20 minutes and 3 more. Started Apr 2011; status: completed.
02
Drugs
nitric oxide
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT01220687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01220687.